Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Molecular quality controls are the quality control which are widely used for the performance of testing procedure specifically for running assays and to verify the precise results. The growing prevalence of infectious diseases, oncology across the country has significantly increased the demand for the market. Furthermore, growing adoption of third-party quality controls has propelled the growth of market to huge extent. Likewise, rising demand for external quality assessment support has accelerated the market growth.
The market in United States is driven by rising number of accredited clinical laboratories across the country where the number of laboratories are adopting molecular quality controls products for precise results full filling the requirement of patient with precise and error free results. In addition, technology adoption in the United States market has significantly propelled the growth of market. Furthered, growing adoption of third-party quality controls and rising demand for external quality assessment support has accelerated the growth of market providing the market with new growth avenue.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the United States molecular quality controls market. In addition, complete analysis of changes on the United States molecular quality controls market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has provided a positive growth for market as number of laboratories were having increasing requirement molecular quality controls products.
The molecular quality controls market comprises of different market segment like product, analyte type, application, end users.
By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Instrument-specific Controls segment further includes PCR, DNA Sequencing & NGS and Other Technologies. Independent controls has increasing demand in the United States molecular quality controls market owing to reduced cost, time saving. Also, it helps in providing enhance the performance with level of standardization thereby is expected to witness the growth at highest pace during the estimated time period. Similarly, instrument-specific controls is expected to grow at moderate rate. In addition, Instrument-specific Controls sub-segment PCR is anticipated to witness the growth highest rate owing to increasing preference and adoption in molecular quality controls market
The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls is expected to lead in United States molecular quality controls market during the forecast period. The growth is due to ability of Multi-analyte control to mimic the sample where it helps in monitoring the performance and verify the accuracy, precision of laboratory techniques. These are mostly present in wide range of format to enhance flexibility for user while performing sample testing. Also, single-analyte controls is expected to witness rising demand in upcoming years.
The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases dominated the market in 2020 and is likely to witness rapid growth in upcoming years. The growth is due to increasing burden of diseases, rising awareness for diagnosis and treatment has further boosted the demand for market. For instance according to CDC, the infectious disease data for U.S. was mentioned where the number of new tuberculosis cases were 9,025 in 2018. Likewise, in 2018, the Number of new salmonella cases were 60,999 and new Lyme disease cases were 33,666. Also, number of new meningococcal disease cases were estimated to be 327 in 2018. The rising number of infectious disease in the United States has ultimately increased the demand for molecular quality controls market
The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories has increasing demand for molecular quality controls as these play major role for ensuring precision and accuracy of patient sample results. Besides, the COVID-19 testing further increased the demand for market in clinical laboratories. In addition, hospitals are expected to witness increasing growth during the time period owing to increasing adoption of different molecular quality controls products in testing, and diagnosis has led the growth of market in United States to huge extent.
The key players in molecular quality controls market are Seracare Life Sciences Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Microbiologics Inc., Zeptometrix, Roche Diagnostics, Abbott Laboratories, Quidel, Qnostics and Maine Molecular Quality Controls Inc. among others.
June 2021: LGC SeraCare had expanded its line of SARS-CoV-2 molecular quality solutions to include AccuPlex SARS-CoV-2 Variant Panel 1. The kit contains full SARS-CoV-2 genomic RNA with a focus on S-gene mutations in three prominent variants of concern with vials.
March 2021: The Abbott Laboratories had announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in one test. Alinity m uses Polymerase Chain Reaction (PCR) technology, which is known for its high sensitivity in detecting infectious diseases.
May 2019: ZeptoMetrix had released NATtrol Parainfluenza control which is a full process control, multiplexed, molecular qualitative quality control that is designed to evaluate the performance of nucleic acid tests for determination of the presence of Parainfluenza Types 1, 2, 3 and 4B.
July 2018: Quidel had announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Solana Bordetella Complete Assay, a molecular diagnostic assay to be used with the Solana molecular diagnostic instrument for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection.
The report analyses the United States molecular quality controls market based on by product, analyte type, application, end users. By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Independent controls has increasing demand in the United States molecular quality controls market owing to reduced cost, time saving. The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls is expected to lead in United States molecular quality controls market. The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases dominated the market in 2020 and is likely to witness rapid growth in upcoming years. The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories has increasing demand for molecular quality controls market.
Why to buy this report:
